Profil
Barry Gumbiner formerly worked at Merck & Co., Inc., as Director-Clinical Research & Metabolism in 2006, Metabasis Therapeutics, Inc., as Chief Medical Officer & VP-Clinical Development in 2009, and Indiana University, as Associate Professor.
Dr. Gumbiner received his undergraduate degree from the University of Southern California and undergraduate degree from the University of California, Los Angeles.
Anciens postes connus de Barry Gumbiner
Sociétés | Poste | Fin |
---|---|---|
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Directeur Technique/Scientifique/R&D | 14/10/2009 |
MERCK & CO., INC. | Directeur Technique/Scientifique/R&D | 01/09/2006 |
Indiana University | Corporate Officer/Principal | - |
Formation de Barry Gumbiner
University of California, Los Angeles | Undergraduate Degree |
University of Southern California | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
MERCK & CO., INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Health Technology |